Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc G Ghany

Showing results (61-70 of 182) with videos related to

Pageof 19
Sort By:
Hepatology (Baltimore, Md.)|September 8, 2011
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver DiseasesMarc G Ghany, David R Nelson, Doris B Strader, et al.
Journal of Viral Hepatitis|April 24, 2021
Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North AmericaStewart L Cooper, Wendy C King, Douglas B Mogul, et al.
Alimentary Pharmacology & Therapeutics|December 1, 2021
Systematic review with meta-analysis: the impact of functional cure on clinical outcomes in patients with chronic hepatitis BAnusha Vittal, Disha Sharma, Alvin Hu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2012
Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis CNaveen Gara, Xiongce Zhao, David E Kleiner, et al.
Plos One|November 1, 2024
Trends in hepatocellular carcinoma and viral hepatitis treatment in older AmericansJoy Jiang, Meredith S Shiels, Donna Rivera, et al.
The Journal of Infectious Diseases|September 22, 2023
Tools Needed to Support Same-Day Diagnosis and Treatment of Current Hepatitis C Virus InfectionGregory P Fricker, Marc G Ghany, Jorge Mera, et al.
Gastroenterology|May 9, 2007
Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapyGlen Lutchman, Susan Danehower, Byung-Cheol Song, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 12, 2025
Changes in Hepatitis B Core Antigen and Hepatitis B Surface Antigen Expression Following Antiviral Therapy and Their Role in Outcome of Patients With Chronic Hepatitis BMohammed Rifat Shaik, Lauren Apodaca, Sungyoung Auh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design ConsiderationsJordan J Feld, Julie Bruneau, Gregory J Dore, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trialMarc G Ghany, Hae-Young Kim, Anne Stoddard, et al.
Pageof 19

Showing results (61-70 of 182) with videos related to

Sort By:
Pageof 19
Hepatology (Baltimore, Md.)|September 8, 2011
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver DiseasesMarc G Ghany, David R Nelson, Doris B Strader, et al.
Journal of Viral Hepatitis|April 24, 2021
Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North AmericaStewart L Cooper, Wendy C King, Douglas B Mogul, et al.
Alimentary Pharmacology & Therapeutics|December 1, 2021
Systematic review with meta-analysis: the impact of functional cure on clinical outcomes in patients with chronic hepatitis BAnusha Vittal, Disha Sharma, Alvin Hu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2012
Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis CNaveen Gara, Xiongce Zhao, David E Kleiner, et al.
Plos One|November 1, 2024
Trends in hepatocellular carcinoma and viral hepatitis treatment in older AmericansJoy Jiang, Meredith S Shiels, Donna Rivera, et al.
The Journal of Infectious Diseases|September 22, 2023
Tools Needed to Support Same-Day Diagnosis and Treatment of Current Hepatitis C Virus InfectionGregory P Fricker, Marc G Ghany, Jorge Mera, et al.
Gastroenterology|May 9, 2007
Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapyGlen Lutchman, Susan Danehower, Byung-Cheol Song, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 12, 2025
Changes in Hepatitis B Core Antigen and Hepatitis B Surface Antigen Expression Following Antiviral Therapy and Their Role in Outcome of Patients With Chronic Hepatitis BMohammed Rifat Shaik, Lauren Apodaca, Sungyoung Auh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design ConsiderationsJordan J Feld, Julie Bruneau, Gregory J Dore, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trialMarc G Ghany, Hae-Young Kim, Anne Stoddard, et al.
Pageof 19